LFST Stock Analysis: Buy, Sell, or Hold?
LFST - LifeStance Health Group, Inc. Common Stock
$6.24
-0.08 (-1.27%)
▼
5d:
-4.44%
30d:
-13.81%
90d:
-12.48%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When LFST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LFST shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: LFST shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.61
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$11.56
46.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LFST is currently trading at $6.24, which is considered oversold relative to its 30-day fair value range of $6.48 to $7.17. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.3) compared to its historical average (25.3). Remarkably, the market is currently pricing in an annual earnings decline of 13.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LFST is in a downtrend. The price is currently testing key support at $6.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LFST has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $9.83 (+57.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LFST is in a downtrend. The price is currently testing key support at $6.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LFST has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $9.83 (+57.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$6.48 -
$7.17
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 57.6% below Wall St target ($9.83)
Fair Price Analysis
30-Day Fair Range
$6.48 -
$7.17
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$6.25
Resistance Level
$6.74
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.32
Wall Street Target
$9.83
(+57.6%)
Revenue Growth (YoY)
17.4%
Profit Margin
0.7%
Valuation Discount vs History
-13.6% cheaper
PE vs Historical
16.3 vs 25.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.6%
(market-implied from PE analysis)
1-Year Target
$5.62
(-10%)
2-Year Target
$5.05
(-19%)
3-Year Target
$4.55
(-27%)
3-Yr Target (if PE normalizes)
(PE: 16→25)
$7.05
(+13%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 26.8%)
$17.44
(+179%)
Base:
(SPY PE: 16.3, Growth: 26.8%)
$12.73
(+104%)
Bear:
(PE: 13.9, Growth: 26.8%)
$10.82
(+74%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (64x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Forward PE: 64.10 | Forward EPS (Implied): $0.10
Bull Case
$7.88
(+21%)
Analyst growth 15.0%, PE expands to 67.3
Base Case
$6.53
(0%)
Market implied 0.0%, PE stable at 64.1
Bear Case
$5.00
(-24%)
Severe decline -15.0%, PE contracts to 57.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.3 to 25.3
Stabilization Target:
$9.67
(+55.0%)
PE Expansion Potential:
+55.0%
Share & Embed Analysis
Last updated: March 31, 2026 3:40 AM ET
Data refreshes hourly during market hours. Next update: 4:40 AM
Data refreshes hourly during market hours. Next update: 4:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Darren M Black
SELL
4314939 shares
2026-03-02
Robert Bessler
SELL
1701 shares
2025-12-22
Robert Bessler
SELL
119942 shares
2025-12-19
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 62 BUY |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 64 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 48 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$140 | 54 HOLD |
